Literature DB >> 6708932

Increased levels of thymidylate synthetase in cells exposed to 5-fluorouracil.

W L Washtien.   

Abstract

The binding of 5-fluoro-2'-deoxyuridylate, methylenetetrahydrofolate, and thymidylate synthetase in a ternary complex results in enzyme inhibition and is a major component of 5-fluorouracil cytotoxicity in some cells. The amount of 5-fluoro-2'-deoxyuridylate bound to thymidylate synthetase in several human gastrointestinal tumor cell lines following 5-fluorouracil exposure was determined, using Sephadex G-25 chromatography and high-pressure chromatographic analysis. These data were compared with previously determined values for thymidylate synthetase levels in control cultures not exposed to 5-fluorouracil. In HuTu 80 cells, the amount of 5-fluoro-2'-deoxyuridylate bound to thymidylate synthetase represented 16% of the total amount of enzyme present in untreated cells. The values for 5-fluoro-2'-deoxyuridylate bound to thymidylate synthetase in the WIDR and HT 29 cell lines (57 and 46 fmoles/10(5) cells, respectively), however, exceed by 3- to 6-fold the total amount of this enzyme found in untreated cells. The presence of increased levels of thymidylate synthetase protein in these cell lines was confirmed by sodium dodecyl sulfate gel electrophoresis. Measurements of thymidylate synthetase levels following exposure of cells to cycloheximide demonstrated that thymidylate synthetase complexed to 5-fluoro-2'-deoxyuridylate has increased stability as compared with uncomplexed enzyme. The level of thymidylate synthetase (bound and free) present in WIDR cells was measured following removal of FUra from the media. After 48 hr, the level of bound enzyme had fallen from 53 to 14 fmoles/10(5) cells, whereas free enzyme, which was undetectable after a 24-hr exposure to FUra, returned to 60% of its level in untreated cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6708932

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  9 in total

1.  Characterization of a cis-acting regulatory element in the protein coding region of thymidylate synthase mRNA.

Authors:  X Lin; L A Parsels; D M Voeller; C J Allegra; G F Maley; F Maley; E Chu
Journal:  Nucleic Acids Res       Date:  2000-03-15       Impact factor: 16.971

2.  Thymidylate synthase in situ protein expression and survival in stage I nonsmall-cell lung cancer.

Authors:  Zhong Zheng; Xueli Li; Michael J Schell; Tingan Chen; David Boulware; Lary Robinson; Eric Sommers; Gerold Bepler
Journal:  Cancer       Date:  2008-06-15       Impact factor: 6.860

3.  Variations in patterns of DNA damage induced in human colorectal tumor cells by 5-fluorodeoxyuridine: implications for mechanisms of resistance and cytotoxicity.

Authors:  C E Canman; H Y Tang; D P Normolle; T S Lawrence; J Maybaum
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

4.  Targeting One Carbon Metabolism with an Antimetabolite Disrupts Pyrimidine Homeostasis and Induces Nucleotide Overflow.

Authors:  Zheng Ser; Xia Gao; Christelle Johnson; Mahya Mehrmohamadi; Xiaojing Liu; Siqi Li; Jason W Locasale
Journal:  Cell Rep       Date:  2016-06-02       Impact factor: 9.423

5.  Cell cycle-dependent expression of thymidylate synthase in Saccharomyces cerevisiae.

Authors:  R K Storms; R W Ord; M T Greenwood; B Mirdamadi; F K Chu; M Belfort
Journal:  Mol Cell Biol       Date:  1984-12       Impact factor: 4.272

6.  Transcriptional activation and cell cycle block are the keys for 5-fluorouracil induced up-regulation of human thymidylate synthase expression.

Authors:  Alessio Ligabue; Gaetano Marverti; Ursula Liebl; Hannu Myllykallio
Journal:  PLoS One       Date:  2012-10-09       Impact factor: 3.240

7.  Trapping of 5-Fluorodeoxyuridine Monophosphate by Thymidylate Synthase Confers Resistance to 5-Fluorouracil.

Authors:  Chinatsu Kurasaka; Nana Nishizawa; Yoko Ogino; Akira Sato
Journal:  ACS Omega       Date:  2022-02-09

8.  Expression of thymidylate synthase in gastric cancer patients treated with 5-fluorouracil and doxorubicin-based adjuvant chemotherapy after curative resection.

Authors:  J Choi; H Lim; D K Nam; H S Kim; D Y Cho; J W Yi; H C Kim; Y K Cho; M W Kim; H J Joo; K B Lee; K B Kim
Journal:  Br J Cancer       Date:  2001-01       Impact factor: 7.640

9.  Molecular Mechanisms and Tumor Biological Aspects of 5-Fluorouracil Resistance in HCT116 Human Colorectal Cancer Cells.

Authors:  Chinatsu Kurasaka; Yoko Ogino; Akira Sato
Journal:  Int J Mol Sci       Date:  2021-03-13       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.